Systolic blood pressure and mortality in patients with atrial fibrillation and heart failure: insights from the AFFIRM and AF‐CHF studies. (9th October 2014)
- Record Type:
- Journal Article
- Title:
- Systolic blood pressure and mortality in patients with atrial fibrillation and heart failure: insights from the AFFIRM and AF‐CHF studies. (9th October 2014)
- Main Title:
- Systolic blood pressure and mortality in patients with atrial fibrillation and heart failure: insights from the AFFIRM and AF‐CHF studies
- Authors:
- Tremblay‐Gravel, Maxime
Khairy, Paul
Roy, Denis
Leduc, Hugues
Wyse, D. George
Cadrin‐Tourigny, Julia
Macle, Laurent
Dubuc, Marc
Andrade, Jason
Rivard, Lena
Guerra, Peter G.
Thibault, Bernard
Ahmed, Ali
Talajic, Mario
Guertin, Marie‐Claude
White, Michel - Abstract:
- <abstract abstract-type="main" id="ejhf168-abs-0001"> <title> <x xml:space="preserve">Abstract</x> </title> <sec id="ejhf168-sec-0001" sec-type="section"> <title>Aims</title> <p id="ejhf168-para-0001">To investigate the association between baseline systolic blood pressure levels and mortality in patients with AF with or without LV dysfunction. Hypertension leads to cardiovascular disease but, in specific groups, low blood pressure has been associated with a paradoxical increase in mortality. In patients with AF and heart failure, the relationship between blood pressure and death remains largely unknown.</p> </sec> <sec id="ejhf168-sec-0002" sec-type="section"> <title>Methods and results</title> <p id="ejhf168-para-0002">We conducted a post‐hoc combined analysis on pooled data from AFFIRM and AF‐CHF trials and assessed the relationship between baseline systolic blood pressure (SBP) and mortality and hospitalizations. Patients were classified according to LVEF (&gt;40%, ≤40%) and baseline SBP (&lt;120 mmHg, 120–140 mmHg, &gt;140 mmHg). A total of 5436 patients with non‐permanent AF were followed for 41 ± 16 months. In patients with LVEF &gt;40%, baseline SBP was not related to mortality using multivariate Cox regression analyses to adjust for baseline differences (<italic>P</italic> = 0.563). In contrast, in patients with LVEF ≤40% (<italic>n</italic> = 1980), SBP &lt;120 mmHg and SBP &gt;140 mmHg were both associated with a significant increase in total mortality compared<abstract abstract-type="main" id="ejhf168-abs-0001"> <title> <x xml:space="preserve">Abstract</x> </title> <sec id="ejhf168-sec-0001" sec-type="section"> <title>Aims</title> <p id="ejhf168-para-0001">To investigate the association between baseline systolic blood pressure levels and mortality in patients with AF with or without LV dysfunction. Hypertension leads to cardiovascular disease but, in specific groups, low blood pressure has been associated with a paradoxical increase in mortality. In patients with AF and heart failure, the relationship between blood pressure and death remains largely unknown.</p> </sec> <sec id="ejhf168-sec-0002" sec-type="section"> <title>Methods and results</title> <p id="ejhf168-para-0002">We conducted a post‐hoc combined analysis on pooled data from AFFIRM and AF‐CHF trials and assessed the relationship between baseline systolic blood pressure (SBP) and mortality and hospitalizations. Patients were classified according to LVEF (&gt;40%, ≤40%) and baseline SBP (&lt;120 mmHg, 120–140 mmHg, &gt;140 mmHg). A total of 5436 patients with non‐permanent AF were followed for 41 ± 16 months. In patients with LVEF &gt;40%, baseline SBP was not related to mortality using multivariate Cox regression analyses to adjust for baseline differences (<italic>P</italic> = 0.563). In contrast, in patients with LVEF ≤40% (<italic>n</italic> = 1980), SBP &lt;120 mmHg and SBP &gt;140 mmHg were both associated with a significant increase in total mortality compared with SBP 120–140 mmHg [hazard ratio (HR) 1.75, 95% confidence interval (CI) 1.41–2.17; and HR 1.40, 95% CI 1.04–1.90, respectively]. Hospitalizations were unrelated to SBP regardless of LVEF.</p> </sec> <sec id="ejhf168-sec-0003" sec-type="section"> <title>Conclusions</title> <p id="ejhf168-para-0003">Mortality is modulated by baseline SBP levels in patients with AF and depressed EF but not in patients with normal EF. Targeted therapy of AF patients based on SBP merits further prospective investigation.</p> </sec> </abstract> … (more)
- Is Part Of:
- European journal of heart failure. Volume 16:Number 11(2014)
- Journal:
- European journal of heart failure
- Issue:
- Volume 16:Number 11(2014)
- Issue Display:
- Volume 16, Issue 11 (2014)
- Year:
- 2014
- Volume:
- 16
- Issue:
- 11
- Issue Sort Value:
- 2014-0016-0011-0000
- Page Start:
- 1168
- Page End:
- 1174
- Publication Date:
- 2014-10-09
- Subjects:
- Heart failure -- Periodicals
Heart Failure -- Periodicals
Insuffisance cardiaque -- Périodiques
Heart failure
Periodicals
616.129005 - Journal URLs:
- http://onlinelibrary.wiley.com/journal/10.1002/(ISSN)1879-0844 ↗
http://rave.ohiolink.edu/ejournals/issn/13889842/ ↗
http://www.sciencedirect.com/science/journal/13889842 ↗
http://onlinelibrary.wiley.com/ ↗ - DOI:
- 10.1002/ejhf.168 ↗
- Languages:
- English
- ISSNs:
- 1388-9842
- Deposit Type:
- Legaldeposit
- View Content:
- Available online (eLD content is only available in our Reading Rooms) ↗
- Physical Locations:
- British Library DSC - 3829.729860
British Library DSC - BLDSS-3PM
British Library HMNTS - ELD Digital store - Ingest File:
- 3973.xml